Online:
Visits:
Stories:
Profile image
Story Views

Now:
Last Hour:
Last 24 Hours:
Total:

Acute Spinal Cord Injury Therapeutic Pipeline Market H2 2014

Wednesday, January 7, 2015 23:17
% of readers think this story is Fact. Add your two cents.

(Before It's News)

RnRmarketResearch.com adds report “Acute Spinal Cord Injury – Pipeline Review, H2 2014” to its store.

 

Acute Spinal Cord Injury – Pipeline Review, H2 2014′, provides an overview of the Acute Spinal Cord Injury’s therapeutic pipeline.

 

This report provides comprehensive information on the therapeutic development for Acute Spinal Cord Injury, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Acute Spinal Cord Injury and special features on late-stage and discontinued projects.

 

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

 

Complete report available @ http://www.rnrmarketresearch.com/acute-spinal-cord-injury-pipeline-review-h2-2014-market-report.html .

 

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

 

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

 

Scope

 

- The report provides a snapshot of the global therapeutic landscape of Acute Spinal Cord Injury

- The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities

- The report reviews key players involved in the therapeutics development for Acute Spinal Cord Injury and enlists all their major and minor projects

- The report summarizes all the dormant and discontinued pipeline projects

- A review of the Acute Spinal Cord Injury products under development by companies and universities/research institutes based on information derived from company and industry-specific sources

- Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages

- A detailed assessment of monotherapy and combination therapy pipeline projects

- Coverage of the Acute Spinal Cord Injury pipeline on the basis of target, MoA, route of administration and molecule type

- Latest news and deals relating related to pipeline products

 

Reasons to buy

 

- Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Develop strategic initiatives by understanding the focus areas of leading companies

- Identify and understand important and diverse types of therapeutics under development for Acute Spinal Cord Injury

- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

- Devise corrective measures for pipeline projects by understanding Acute Spinal Cord Injury pipeline depth and focus of Indication therapeutics

- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

 

Inquire for Discount @ http://www.rnrmarketresearch.com/contacts/discount?rname=256144 .

(This is a premium report priced at US$2000 for a single user PDF.)

 

List of Tables

 

Number of Products under Development for Acute Spinal Cord Injury, H2 2014 7

Number of Products under Development for Acute Spinal Cord Injury – Comparative Analysis, H2 2014 8

Number of Products under Development by Companies, H2 2014 9

Number of Products under Investigation by Universities/Institutes, H2 2014 10

Comparative Analysis by Clinical Stage Development, H2 2014 11

Comparative Analysis by Early Stage Development, H2 2014 12

Products under Development by Companies, H2 2014 13

Products under Investigation by Universities/Institutes, H2 2014 14

Acute Spinal Cord Injury – Pipeline by Acorda Therapeutics, Inc., H2 2014 15

Acute Spinal Cord Injury – Pipeline by Kringle Pharma, Inc., H2 2014 16

Acute Spinal Cord Injury – Pipeline by Neuralstem, Inc., H2 2014 17

Acute Spinal Cord Injury – Pipeline by Neuronax SAS, H2 2014 18

Assessment by Monotherapy Products, H2 2014 19

Number of Products by Stage and Target, H2 2014 21

Number of Products by Stage and Mechanism of Action, H2 2014 23

Number of Products by Stage and Route of Administration, H2 2014 25

Number of Products by Stage and Molecule Type, H2 2014 27

Acute Spinal Cord Injury Therapeutics – Recent Pipeline Updates, H2 2014 41

Acute Spinal Cord Injury – Dormant Projects, H2 2014 49

 

Purchase a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=256144 .

 

About Us:

RnRmarketResearch.com is your single source for all market research needs. Our database includes 450,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets. We offer you customization options on reports by & custom reports through MarketsandMarkets.com. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.

Report abuse

Comments

Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories

Register

Newsletter

Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.